ArticleCancer reports (Hoboken, N.J.)2022

Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments.

Hideki Nawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.